The receptor’s aberrant abnormal activation found in cancer can obey different mechanisms, including receptor overexpression, mutation, ligand-dependent receptor dimerization, and ligand-independent activation is a receptor tyrosine kinase of the ErbB family that is abnormally activated in many epithelial tumors. Here, EGFR is linked to cancer.